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Background: This study compared the clinical efficacies, advantages and disadvantages of two transplantation
approaches for treating spinal cord injury: open surgical exploration combined with local stem cell transplantation
(referred to as open surgical transplantation) and local stem cell transplantation by CT-guided puncture (referred to
as CT-guided transplantation).
Methods: The patients were divided into the following three groups to perform a retrospective controlled study:
Group A included nine patients who underwent open surgical transplantation, Group B included nine patients who
underwent CT-guided transplantation, and Group C included nine patients who did not receive stem cell transplantation.
The Abbreviated Injury Scale (AIS), the American Spinal Injury Association (ASIA) score and the motor evoked potentials
(MEP) examination were utilized to compare the differences in the clinical efficacies. The advantages and disadvantages
of the two transplantation approaches were also compared, including the surgical risks, the possibility of repeating
the operation, the interval between surgery and rehabilitation exercises and the scope of conditions suitable
for the operation.
Results: Whether evaluated by the AIS grading scale, the ASIA score or the MEP results, there were
significant differences in the clinical efficacy among the three patient groups. Group B exhibited the best clinical
outcome, followed by Group A, and Group C fared the worst. The CT-guided transplantation had the advantages of
lower surgical risk, the potential to repeat the operations within a short time-frame and a short interval between
surgery and rehabilitation exercise compared with the open surgical transplantation. The conditions that are suitable
for CT-guided transplantation versus the conditions suitable for open surgical transplantation are not identical. The
application scopes for the two approaches had their respective strengths.
Conclusions: CT-guided stem cell transplantation was confirmed as a safe and effective approach to treat sequelae of
spinal cord injury with the advantages of simpler operation, minimal invasion, less adverse reaction and quicker recovery.
Trial registration: Clinical trials registration number: ChiCTR-TNRC-12002477.
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In both basic research and clinical applications, trans-
plantations of mesenchymal stem cells (MSCs) derived
from a variety of sources have been used to treat spinal
cord injury (SCI) with positive results, as indicated by
the efficacy and safety of this technique [1,2]. The
current view is that the mechanism underlying stem cell
(SC) treatments for SCI is associated with neuron re-
placement [3]; axonal regeneration and remyelination
[4,5], neuronal protection [6-8]; promotion of vascular
regeneration and improvement of the local blood supply
[9-11]; induction of endogenous neural SC migration [12];
and regulation of the local inflammatory environment,
systemic immune response and inflammatory response
[13]. There are three commonly used cell transplantation
approaches: local transplantation into the lesioned area
[14], subarachnoid transplantation [15] and intravenous
infusion [16]. Local transplantation into the lesioned area
is the most commonly used technique and is considered
the most effective approach [17] for treating SCI by SC
transplantation. The classical procedure is open surgical
exploration combined with local SC transplantation for
SCI (referred to as open surgical transplantation), which
involves exposing the injured spinal cord and the upper
and lower edges of the normal spinal cord tissue by open
surgery and performing intra-spinal cell transplantation
under direct view [18]. This operation has the disadvan-
tages of being high-risk and involving extensive trauma.
There is a low potential to repeat the operation, and a
long postoperative recovery is required before rehabilita-
tion exercises can begin. To overcome these disadvan-
tages, we developed a novel local SC transplantation
technique for treating SCI. This method involves local SC
transplantation by computed tomography (CT)-guided
puncture for the treatment of SCI (referred to as CT-




Nine patients (8 male and 1 female) who previously re-
ceived open surgical transplantation in our hospital were
selected for this study. The patients’ mean (±SD) age
was 36 ± 9.68 years, and their mean disease duration was
18.67 ± 7.68 months. Five cases were cervical SCIs, four
cases were thoracic SCIs, six cases were complete injur-
ies, and three cases were incomplete injuries. Preopera-
tively, six cases were identified as ASIA (American Spinal
injury Association) Impairment Scale (AIS) grade A,
one case was identified as grade B, and two cases were
identified as grade C. Nine comparable cases from pa-
tients who received CT-guided transplantation and nine
patients with SCI who did not receive SC transplantation
were selected using age, duration of the disease, site ofinjury and degree of injury as the screening criteria. To-
gether, these 27 patients made up the following groups:
Group A patients received open surgical transplantation,
Group B received CT-guided transplantation, and Group
C received no SC transplantation. All the subjects in three
groups were chronic SCI survivors and received decom-
pression and internal fixation surgery at their acute phase
of SCI. For Group A patients, the exclusion criteria in-
cluded the following: (1) patients with inflammation or
skin ulceration at the surgical site, (2) patients with a
bleeding tendency or coagulation defects, (3) patients in
poor general condition who could not tolerate surgery
and (4) patients with systemic organ dysfunction who
could not tolerate surgery. To minimize the influence
of other factors that could also affect neurological re-
habilitation during the assessment of the efficacy of SC
transplantation, the following circumstances were also
excluded from Group A: (1) patients who still showed re-
covery trends in terms of nerve function, (2) patients with
adhesions at the injury site that required surgical interven-
tion, (3) patients with significant compressive lesions at
the injury site that required surgical intervention, (4) pa-
tients with progressive loss of nerve function for unknown
reasons, (5) patients with associated syringomyelia who
required surgical intervention and (6) patients with associ-
ated spinal cord or epidural vascular malformations that
required surgical intervention. For Group B patients, the
exclusion criteria included the following: (1) patients who
still showed recovery trends in terms of nerve function,
(2) patients with adhesions at the injury site that required
surgical intervention, (3) patients with significant com-
pressive lesions at the injury site that required surgical
intervention, (4) patients with progressive loss of nerve
function for unknown reasons, (5) patients with asso-
ciated syringomyelia that required surgical interven-
tion, (6) patients with associated spinal cord or epidural
vascular malformations that required surgical intervention
and (7) patients who could not be in the prone position or
who could not remain in the prone position for more than
30 minutes. The selected patients did not differ in terms
of rehabilitation exercises or other aspects of the treat-
ment. The details of the patients are listed in Table 1. To
avoid the influence of drugs on the neurological rehabilita-
tion by nourishing the nerves and improving the microcir-
culation, the three groups of patients did not receive
treatments with these drugs. To exclude the effect of re-
habilitation exercises on neurological rehabilitation, the
three groups of patients received formal rehabilitation ex-
ercises at the same hospital during the observation period.
The study protocol was approved by the Committees of
Ethics in Research of the General Hospital of Chinese
People’s Armed Police Forces. All of the patients provided
written informed consent and confirmed their willingness
to receive UCMSC injection.










Before surgery Six months after surgery
A1 Male 28 14 C4-7 A B
B1 Male 30 16 C4-6 A B
C1 Male 25 13 C4-7 A A
A2 Male 45 13 T8-10 B C
B2 Male 47 17 T8-9 B C
C2 Male 45 15 T8-9 B B
A3 Male 30 16 T5-9 A A
B3 Male 33 18 T7-8 A A
C3 Male 29 16 T6-9 A A
A4 Female 52 19 C4-5 A B
B4 Female 51 23 C4-5 A B
C4 Female 51 17 C3-5 A A
A5 Male 24 14 C6-7 A A
B5 Male 26 17 C5-6 A B
C5 Male 27 15 C5-6 A B
A6 Male 38 16 T1 A A
B6 Male 35 19 T1-2 A A
C6 Male 36 13 T1-2 A A
A7 Male 26 21 C4-6 A B
B7 Male 27 24 C4-7 A B
C7 Male 26 18 C4-7 A A
A8 Male 44 38 C5-6 B B
B8 Male 46 36 C5-6 B C
C8 Male 47 42 C5-6 B B
A9 Male 37 17 T5-6 C C
B9 Male 39 21 T4-6 C C
C9 Male 36 14 T5 C C
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Healthy pregnant women of normal gestational age who
would undergo caesarean sections were selected. After
obtaining signed written consent, an approximately
10 cm long section of the umbilical cord was removed
during the surgery. The Wharton’s jelly was obtained
after removing the surface amnion and blood vessels
within the umbilical cord under sterile conditions, rinsed
three times in normal saline, cut into small pieces
with a size of approximately 0.5 cm3 and cultured in
Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum. The residual tissue blocks were
removed after 7–10 days. The cells that attached to
the walls of the culture flask were trypsinized with
0.25% trypsin. The harvested cells were reseeded, and
the medium was changed every 3 days. The cells were pas-
saged every 5–7 days, then were frozen and stored inliquid nitrogen. Before being used for transplantation, the
cells were thawed, cultured for 3 days. The flow cytometry
was performed to detect the cell purity. All the percent-
ages of CD105, CD90, CD73 and CD44 were higher than
95%, while none percentage of CD19, CD45, CD11b or
CD34 were higher than 5%. Then the cells were used for
transplantation. The results of flow cytometry were pre-
sented in Figure 1.
Preparation of UCMSC
For the Group A and Group B patients, SCs were col-
lected preoperatively, resuspended in normal saline to
generate a cell suspension. For patients in Group A,
50 μl cell suspension (cell concentration was 8 × 105
cells/μl) was injected into two sites of the spinal cord,
25 μl at each site. Totally 4 × 107 cells were transplanted.
For patients in Group B, 50 μl cell suspension (cell
Figure 1 CT machine ascertainment of the intended cell puncture
site, direction and depth. a, An axial (transverse) image. The red line
indicates the upper intervertebral space of the intended puncture site
and the direction. The green line shows that the intended puncture
site is 3 cm away from the left edge of the marker. b, A sagittal image.
The pink line represents the upper intervertebral space of the intended
puncture site and the direction. The blue line shows the intended
puncture depth of 7 cm, and the green line shows that the intended
puncture site is located 1.9 cm below the upper marker.
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two sites of the spinal cord, 25 μl at each site. The
transplantation was repeated once. Totally 4 × 107 cells
were transplanted.
UCMSC transplantation
The patients in Group A received intravenous combined
anesthesia in the prone position. The SCI site and the
proximal and distal extensions of one vertebral body
were completely exposed by the posterior midline ap-
proach, and the spinous process and lamina were re-
moved carefully using rongeurs until the normal spinal
cord was revealed. The dura was opened from the pos-
terior midline under a microscope, and the prepared cell
suspension was injected into both sides of the normal
spinal cord near the injury site (the junction between the
normal and abnormal spinal cord). The dura was then
sutured tightly, and the wound was closed by conven-
tional wound closure. After surgery, the patients were
placed in the supine position, laid on hard wood plankbeds, fixed to protect the surgical site and turned to
the axial position for three weeks. The patients were
turned over to prevent pressure ulcer occurrence and
their legs were massaged to prevent venous thrombosis
every 2 hours. Rehabilitation exercises were then initiated.
The patients in Group B were kept in the prone position
on the mobile bed of a CT machine, and the vital
signs were monitored with a multifunctional monitor.
The intervertebral space for the intended puncture was
determined according to the site of the injury revealed by
preoperative magnetic resonance imaging (MRI) and the
sensory disturbance level of the patients determined
by physical examination. The upper and lower ends
of the normal spinal cord closest to the site of injury
were used as the intended transplantation targets, and
the intervertebral space for the intended puncture
was further clarified based on the transplantation sites
(Figure 2). The spiral CT scan parameters were 0.625 mm
thickness, 120 kV and 50 mA. The intended puncture site,
puncture direction and depth were determined based on
the intervertebral space for the intended puncture, and
the transplantation targets were based on the processing
station of the CT machine (Figure 3). After surgery, the
patients were kept in the prone position for six hours.
Each patient received CT-guided transplantations twice,
with an interval of at least 10 days. The rehabilitation
exercises began on the first postoperative day after the full
course of treatment was completed. None of the patients
in Group C received any form of SC transplantation ther-
apy and they were treated with rehabilitation exercises
alone.Patient follow-up
The Group A and Group B patients were examined at
our hospital six months after receiving SC transplant-
ation. The Group C patients were examined in our hos-
pital six months after enrollment.Evaluation of neurological function and
electroneurophysiological examination
For the patients in Group A and B, evaluations of neuro-
logical function and electroneurophysiological examina-
tions were performed prior to the SC transplantation
and six months after completing the treatment. Neuro-
logical function was evaluated using the AIS grading scale
and the ASIA standard developed by the ASIA [19]. The
electroneurophysiological examination was conducted for
the motor evoked potentials (MEP) evoked by the upper
and lower limb movement. Group C patients received the
neurological function evaluations and the electroneuro-
physiological examinations at enrollment and after a
six-month interval. All the neurological evaluations were
performed by two professional assessors who were blind
Figure 2 Phenotype analysis of human UC-MSCs by flow cytometry assay. All the percentages of CD105, CD90, CD73 and CD44 were
higher than 95%, while none percentage of CD19, CD45, CD11b or CD34 were higher than 5%.
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rehabilitation exercises in one hospital.
Statistical analysis
The study data were analyzed using SPSS13.0 statistics
software. The measurement data are expressed as the
means ± standard deviations. The before and after scores
for each group were compared using paired t-tests. The
scores were compared among the three groups using
one-way ANOVA. P < 0.05 was considered statistically
significant.
Results
Characterization of local stem cell transplantation by CT-
guided puncture is presented in Supporting Information.
AIS grading
In Group A, four cases exhibited changes in the AIS
grade, and the improvement rate was 44.4%. Patients 1,
4 and 7 improved from grade A to grade B, Patient 2 im-
proved from grade B to grade C and the other patients
did not exhibit changes in the AIS grading. In Group B,
six patients exhibited changes in the AIS grade, with an
improvement rate of 66.7%. Patients 1, 4, 5 and 7improved from grade A to grade B, Patients 2 and 8 im-
proved from grade B to grade C and the other patients
did not exhibit changes in the AIS grading. In Group C,
one case exhibited a change in the AIS grade, with an
improvement rate of 11.1%. Patient 5 improved from
grade A to grade B, and the other patients did not
exhibit changes in the AIS grading. There were signifi-
cant differences in the changes in the AIS grading be-
tween the three groups of patients (P < 0.01), with
Group B showing the most significant improvement,
followed by Group A. Group C had the worst improve-
ment rate (Table 1).ASIA score
In Group A and Group C, the preoperative motor score
was 29.11 ± 22.55 and 29.11 ± 22.55, and the score was
31.3 ± 23.42 and 30.00 ± 23.28 at six months after oper-
ation, there was no significant difference compared to
the baseline in both of two groups (P > 0.05). In Group B,
the preoperative score was 28.67 ± 22.45 and the score six
months after surgery was 36.44 ± 21.21. There was a sig-
nificant difference between these two values (P = 0.008)
(Table 2).
Figure 3 Magnetic resonance imaging ascertainment of the local
stem cell transplantation target by CT-guided puncture before
operation. a, Cervical MRI indicating that the patient had a C3-C6 injury;
thus, the upper intervertebral space to be punctured was C3-C4, and
the lower intervertebral space was C7-T1. The red line indicates the
upper intervertebral space (C3-C4) to be punctured and the intended
target for cell transplantation. The green line represents the upper
intervertebral space (C7-T1) for the intended puncture and the intended
cell transplantation site. b, c, d, The spinal cord conditions of the upper
and lower targets designated for stem cell transplantation, indicating
that the targeted sites in the spinal cord were healthy in appearance,
contained no obvious lesions and were close to the injury site.
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was 39.11 ± 27.08 and 38.00 ± 26.67, the score six months
after surgery was 44.78 ± 26.78 and 53.33 ± 23.83. There
was a significant difference at pain score between pre-
operation and 6 months (P = 0.006 in Group A; P = 0.002
in Group C). In Group C, the first score was 39.78 ±
26.86, and the score six months later was 41.33 ± 26.55.
There was no significant difference between these two
values (P = 0.11).
In Group A, the preoperative light touch score was







Motor 9 Before surgery 29.11 ± 22.55
After surgery 31.33 ± 23.42 0
Pain sensation 9 Before surgery 39.11 ± 27.08
After surgery 44.78 ± 26.78 0
Light touch sensation 9 Before surgery 40.22 ± 26.64
After surgery 48.22 ± 26.18 0
ASIA total score 9 Before surgery 108.44 ± 72.78
After surgery 124.33 ± 72.39 0was 48.22 ± 26.18. There was a significant difference
between these two values (P = 0.008). In Group B, the
preoperative score was 39.11 ± 27.15 and the score six
months after surgery was 56.00 ± 23.07. There was a sig-
nificant difference between these two values (P = 0.004).
In Group C, the first score was 40.22 ± 27.27, and the
score six months later was 42.11 ± 26.77. There was no
significant difference between these two values (P = 0.135).
In Group A, the preoperative ASIA total score was
108.44 ± 72.78 and the score six months after surgery
was 124.33 ± 72.39. There was a significant difference
between these two values (P = 0.009). In Group B, the
preoperative score was 105.78 ± 72.86 and the score six
months after surgery was 145.78 ± 63.06. There was a sig-
nificant difference between these two values (P = 0.002).
In Group C, the first score was 109.11 ± 73.23, and the
score six months later was 113.44 ± 72.88. There was no
significant difference between these two values (P = 0.075).
The assessment changes (delta value) of motor, pain,
light touch and total scores of each individual from the
baseline to the end of the follow-up were summarized in
Table 3. The results showed that there were significant
differences in motor, pain sensation, light touch sensation
and ASIA total scores among Group A, B and C. Patients
in Group B showed the most significant improvement,
followed by patients in Group A. The patients in Group C
showed the least improvement (Table 3).
MEP examination
In Group A, preoperative: All four limbs of Patients 1, 4,
5, 7 and 8 failed to elicit MEP waveforms. The limbs of
Patient 9 generated recordable MEP, with the MEP of
the upper limbs showing normal latency and amplitude
and the MEP of the lower limbs showing delayed latency
and low amplitude. The upper limbs of Patients 2, 3 and
6 all led to recordable MEP with normal latency and
amplitude, but the lower limbs failed to elicit MEP wave-
forms. Six months after surgery: The right lower limb of
Patient 2 elicited an MEP waveform. However, whene points
Group B Group C
value Mean ± Standard
deviation
P value Mean ± Standard
deviation
P value
28.67 ± 22.45 29.11 ± 22.55
.149 36.44 ± 21.21 0.008 30.00 ± 23.28 0.052
38.00 ± 26.67 39.78 ± 26.86
.006 53.33 ± 23.83 0.002 41.33 ± 26.55 0.111
39.11 ± 27.15 40.22 ± 27.27
.008 56.00 ± 23.07 0.004 42.11 ± 26.77 0.135
105.78 ± 72.86 109.11 ± 73.23
.009 145.78 ± 63.06 0.002 113.44 ± 72.88 0.075
Table 3 Assessment changes(delta value)in the ASIA scores over time among the three groups of patients
Motor Pain Light touch Total score
ΔA 2.22 ± 4.18 (ab) 5.67 ± 4.64 (ab) 8.00 ± 6.78 (ab) 15.89 ± 13.93 (ab)
ΔB 7.78 ± 6.63 (ab, bc) 15.33 ± 10.00 (ab, bc) 16.89 ± 12.64 (ab, bc) 40.00 ± 27.48 (ab, bc)
ΔC 0.89 ± 1.17 (bc) 1.56 ± 2.60 (bc) 1.89 ± 3.40 (bc) 4.33 ± 6.34 (bc)
P value 0.009 0.001 0.004 0.001
Note: ab indicates that the comparison of the improvements in the scores between Group A and Group B yielded P < 0.05; bc indicates that the comparison of
the improvements in the scores between Group B and Group C yielded P < 0.05.
Dai et al. Journal of Translational Medicine 2013, 11:315 Page 7 of 10
http://www.translational-medicine.com/content/11/1/315compared with the normal waveform, it exhibited de-
layed latency and reduced amplitude. The right upper
limb of Patient 8 elicited an MEP waveform. However,
when compared with the normal waveform, it exhibited
delayed latency and decreased amplitude. The MEP
waveforms from both lower limbs of Patient 9 were im-
proved, manifested as a reduced delay in the latency and
increased amplitude. The other patients did not show
significant improvement.
In Group B, preoperative: All four limbs of Patients 1,
4, 5, 7 and 8 failed to elicit MEP waveforms. All four
limbs of Patient 9 could elicit an MEP, with the MEP of
the upper limbs exhibiting normal latency and amplitude
and the MEP of the lower limbs showing delayed latency
and reduced amplitude. For Patients 2, 3, and 6, MEP
with normal latency and amplitude were recorded from
both upper limbs, whereas the lower limbs failed to elicit
MEP waveforms. Six months after surgery: The right
lower limb of Patient 2 elicited an MEP waveform. How-
ever, compared with the normal waveform, it showed
delayed latency and reduced amplitude. The MEP from
both lower limbs of Patient 9 showed some improvement,
with shortened latency and increased amplitude, com-
pared with the pre-treatment MEP. The other patients did
not show significant improvement.
In Group C, first time: The four limbs of patients 1, 4,
5, 7 and 8 all failed to elicit MEP waveforms. MEP could
be recorded from Patient 9, with the MEP from the
upper limbs exhibiting normal latency and amplitude
and the MEP from the lower limbs showing delayed
latency and reduced amplitude. For Patients 2, 3 and 6,
MEP with normal latency and amplitude could be re-
corded from the upper limbs, whereas the lower limbs
failed to elicit MEP waveforms. Six months later: all pa-
tients failed to show significant improvement.
Surgical risk
The intra-operative blood loss per patient in Group A
was 230–360 ml, with an average of 192.22 ± 46.38 ml.
The surgical duration was 150–180 minutes, with an
average of 167.78 ± 10.03 minutes. There was neither
pressure ulcer nor venous thrombosis occurrence in all
post-operative patients. The Group A patients did not
experience risk associated with X-ray radiation. TheGroup B patients did not experience intra-operative blood
loss, and the operation duration was 25–50 minutes, with
an average of 34.44 ± 8.08 min. The total dose of X-ray
radiation received during a single surgery was 121.5-
215.3 mGy, with an average of 164.12 ± 27.37 mGy. There
were significant differences in the intra-operative blood
loss, duration of surgery and the X-ray radiation dose re-
ceived during the operation between the two groups
(Table 4).
Adverse reactions
None of the Group A or Group B patients experienced
complications, such as intracranial or extracranial infec-
tion and deteriorated symptoms. The two groups of pa-
tients were then compared in terms of the following
adverse reactions. (1) Fever: In Group A, Patients 2 and
5 experienced fever, and the incidence was 22.2% (2/9);
In Group B, Patient 4 had a fever, and the incidence was
11.1% (1/9). (2) Headache and dizziness: In Group A,
Patients 1 and 6 experienced these symptoms, and the
incidence was 22.2% (2/9); In Group B, Patient 4 experi-
enced these symptoms, and the incidence was 11.1%
(1/9). (3) Nerve radicular pain: In Group A, Patients
2 and 6 exhibited symptoms, and the incidence was
22.2% (2/9); in Group B, Patients 1 and 5 exhibited
symptoms, and the incidence was 11.1% (1/9).
Postoperative recovery time before rehabilitation exercises
The Group A patients required a three-week postopera-
tive fixing and protection time before initiating rehabili-
tation exercises; the Group B patients could begin
rehabilitation exercises on the first day after surgery.
The postoperative recovery time before rehabilitation ex-
ercises of the Group B patients was significantly shorter
than for the Group A patients.
Discussion
In this study, the two sets of AIS grades, ASIA scores
and MEP results from the three groups of patients con-
firmed that local SC transplantation for SCI via either of
two surgical techniques, CT-guided transplantation or
open surgical transplantation, can effectively improve
the neurologic dysfunction associated with SCI. The
clinical outcomes in the two treated groups were













Postsurgery adverse reaction (incidence %)
Fever Headache dizziness Neural radicular pain
Group A 266.67 ± 70.1 241.11 ± 29.34 Yes None General Difficult 22.2 22.2 11.1
Group B None 34.44 ± 8.08 No 164.12 ± 27.37 Local Easy 11.1 11.1 11.1
Attached figures:
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did not receive SC transplants. In addition, the clinical
efficacy in the Group B patients, who received CT-
guided transplantation, was significantly better than in
the Group A patients, who underwent open surgical
transplantation. Furthermore, compared to open surgical
transplantation, CT-guided transplantation was associ-
ated with significantly lower risks with respect to intra-
operative blood loss, surgical duration, protection of the
stability of the spine, anesthesia, operative difficulty and
postoperative adverse reactions. Although CT-guided
transplantation carries the X-ray-induced risk, the dose
of X-ray radiation received by patients per treatment is
far below the safety standard. We thus believe that the
surgical risk of CT-guided transplantation is less than
that of open surgical transplantation and that CT-guided
transplantation is a safer SC transplantation approach.
However, the two transplantation approaches each have
their own advantages and disadvantages in terms of
suitable and incompatible conditions. For the same con-
ditions suitable for treatment by either approach, CT-
guided transplantation can completely replace open surgical
transplantation.
The conclusions of the clinical efficacy evaluation
based either on the AIS grade or ASIA score were not
consistent. The main reason is that the patients’ im-
provements in motor ability, pain sensation and light
touch sensation were inconsistent, and the AIS grading
scale is relatively general. Therefore, the ASIA scores
can be used to individually evaluate the changes in the
above three aspects. This study identified changes in the
patients before and after transplantation, which are not
necessarily revealed by the AIS grading. For example,
Patient 8 in Group A was classified as grade B according
to the AIS grading before SC transplantation. After
treatment by SC transplantation, the patient’s pain and
light touch scores were significantly improved. However,
because the motor score did not exhibit significant
improvement, the AIS grading of the patient did not
change and remained grade B. Therefore, the ASIA
score is more detailed and sensitive than the AIS grading
for evaluating improvements in neurological function.
The MEP examination results suggested that the appli-
cation of SC transplantation could improve neurological
dysfunction in patients with SCI. The MEP is the elec-
trical signal recorded in the distal spinal cord, peripheralnerve or muscles after stimulating the central nervous
system. Therefore, MEP can directly reflect the func-
tional status of the spinal cord descending fiber tracts
and the peripheral motor nerves. The latency is the time
frame between the stimulus initiation and a certain point
of the response. The length of the latency is associated
with the nerve fiber diameter and the size of the alpha
motor fibers, which have the fastest conduction speed.
The amplitude reflects the number of nerves measured
and the degree of synchronized excitement, reflecting
the total number of nerves and muscles involved in the
implementation of the function. The MEP examination
results showed that some patients regained MEP starting
from zero, indicating that both the excitations leading to
nerve impulses and the number of nerve fibers partici-
pating in the impulse were increased from zero. Some
patients only exhibited shortened latency, whereas the
amplitude showed no obvious improvement, suggesting
that the conduction function of the spinal cord motor
tracts was improved but that the number of fibers
involved in nerve impulse conduction and the degree of
excitement showed no significant improvement. The
MEP findings do not fully agree with results from the
AIS grade and ASIA score, which may be explained by
the stimulation sites selected for the MEP examination.
For example, when performing the upper limb MEP
examination, the stimulation sites included the abductor
muscle of the bilateral little fingers. However, the ab-
ductor muscle of the little finger is represented by the
cervical spinal cord segment VII. If the injury site of the
patient was located above cervical VII, the MEP wave-
form could not be elicited during the MEP examination.
After SC transplantation therapy, if the relief of symp-
toms was manifested as a reduction in the sensory level
or if the motor improvement was not sufficient to trig-
ger an MEP, the MEP waveform would not be produced.
Thus, under this circumstance, the MEP test results are
not consistent with the AIS grade and the ASIA score.
Based on the AIS grading, ASIA scores and MEP
results, both local SC transplantation approaches can ef-
fectively improve the neurologic dysfunction in patients
with SCI. Of these approaches, CT-guided transplant-
ation had the best efficacy, followed by open surgical
transplantation; Group C showed no significant effects.
To eliminate as many of the confounding factors that
affect the analysis of the effects of SC transplantation,
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nerve function and cases with an unexplained decline in
neurological function when screening for cases. Patients
with adhesions at the injury site; obvious compressive le-
sions, syringomyelia or dural vascular malformations
that required surgical intervention were also excluded.
Therefore, the possibility of improving the neurological
dysfunction by performing the corresponding surgeries
for these diseases was minimized in this study. When
designing this study, we ruled out the influences of
drugs that nourish nerves or improve the microcircula-
tion and of rehabilitation exercises. Therefore, the con-
clusion drawn from the results of this study that SC
transplantation facilitates the rehabilitation of neuro-
logical functions for patients with SCI is reliable.
Based on the results, we conclude that CT-guided trans-
plantation has many advantages compared with open
surgical transplantation. (1) When comparing the intra-
operative blood loss, duration of surgery and postoperative
adverse reactions, CT-guided transplantation has distinct
advantages as compared with open surgical transplant-
ation. (2) Because open surgical transplantation requires
opening the muscles, the spinous process and the lamina
that stabilize spinal structure, this method can undermine
the stability of the spine. In contrast, CT-guided trans-
plantation does not change the anatomy of the structure
that maintains the stability of the spine. It has obvious ad-
vantages in maintaining spinal stability. (3) CT-guided
transplantation only requires a 9-gauge or 7-gauge punc-
ture needle for the treatment. Because the diameters of
the needles were only 0.9 mm and 0.7 mm, respectively,
the surgical trauma is much less. The main difficulty in
this operation is to adjust the puncture direction, but the
operation is relatively simple. In contrast, open surgical
transplantation requires the relevant knowledge and oper-
ation skills, including the anatomy of the spine, spine
dynamics and structure, surgical incision, how to stop
bleeding and microsurgery. It demands a wealth of basic
knowledge and skilled surgical techniques. The difficulty
of the surgery is significantly increased as compared with
CT-guided SC transplantation. (4) CT-guided transplant-
ation utilizes local anesthesia with very low anesthesia risk.
In contrast, open surgical transplantation requires general
anesthesia with higher anesthesia risks.
For CT-guided transplantation, the patients required
multiple CT scans, thus exposing them to the risk of
X-ray radiation, whereas the patients who received open
surgical transplantation had no such risk. Therefore, it
is necessary to assess the risks of the patients receiving
X-ray radiation. Security requirements of the Association
of the Heads of European Radiological Protection state
that the accumulated amount of radiation received per
person per year should not exceed 50 mSv, which is
equivalent to 2,000 mGy, and that the accumulatedamount of radiation received per person in 5 years should
not exceed 100 mSv, which is equivalent to 4,000 mGy.
During the CT-guided cell transplantation, we utilized low
amp scans. For all nine patients, the dose of X-ray radia-
tion received during each operation was 121.5-215.3 mGy,
with an average of 164.12 ± 27.37 mGy. This amount is
far below the safety standard developed by the Associ-
ation of the Heads of European Radiological Protection.
During the surgical operation, the doses of X-ray radi-
ation to which the patients are exposed can be further
reduced by decreasing the voltage and current during
the CT scan and simultaneously increasing the spiral
slice thickness. Thus, the dose of radiation received by
patients undergoing CT-guided transplantation is within a
safe range.
To the best of our knowledge, this is the first study to
use CT-guided UCMSC transplantation in the treatment
of spinal cord injury. However, some limitations of this
study need to be considered. We only chose 9 patients
in one group and 6 month time-points to explore the
therapeutic effects of UCMSCs. More cases and follow-
up time-points will be required to explore the safety and
mechanisms of UMCSC transplantation. Thus, we can-
not entirely exclude that some of the above-mentioned
limitations may have influenced our results.
Conclusions
CT-guided stem cell transplantation is a safe and effect-
ive approach to treat sequelae of spinal cord injury with
the advantages of simpler operation, minimal invasion,
less adverse reaction and quicker recovery. It can replace
open surgical transplantation to a large extent.
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